- Home
- NVAX vs SPHR Comparison
NVAX vs SPHR Comparison
Compare NVAX & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SPHR
- Stock Information
- Founded
- NVAX 1987
- SPHR 2020
- Country
- NVAX United States
- SPHR United States
- Employees
- NVAX N/A
- SPHR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SPHR Services-Misc. Amusement & Recreation
- Sector
- NVAX Health Care
- SPHR Consumer Discretionary
- Exchange
- NVAX Nasdaq
- SPHR Nasdaq
- Market Cap
- NVAX 1.3B
- SPHR 1.3B
- IPO Year
- NVAX 1995
- SPHR N/A
- Fundamental
- Price
- NVAX $6.47
- SPHR $38.56
- Analyst Decision
- NVAX Buy
- SPHR Buy
- Analyst Count
- NVAX 5
- SPHR 10
- Target Price
- NVAX $16.60
- SPHR $46.70
- AVG Volume (30 Days)
- NVAX 6.2M
- SPHR 527.8K
- Earning Date
- NVAX 08-07-2025
- SPHR 08-13-2025
- Dividend Yield
- NVAX N/A
- SPHR N/A
- EPS Growth
- NVAX N/A
- SPHR N/A
- EPS
- NVAX 2.97
- SPHR N/A
- Revenue
- NVAX $1,254,962,000.00
- SPHR $1,031,650,000.00
- Revenue This Year
- NVAX $56.85
- SPHR $9.19
- Revenue Next Year
- NVAX N/A
- SPHR $6.40
- P/E Ratio
- NVAX $2.17
- SPHR N/A
- Revenue Growth
- NVAX 25.92
- SPHR 16.89
- 52 Week Low
- NVAX $5.01
- SPHR $23.89
- 52 Week High
- NVAX $17.81
- SPHR $50.88
- Technical
- Relative Strength Index (RSI)
- NVAX 39.95
- SPHR 57.23
- Support Level
- NVAX $6.26
- SPHR $37.94
- Resistance Level
- NVAX $7.80
- SPHR $40.06
- Average True Range (ATR)
- NVAX 0.36
- SPHR 1.18
- MACD
- NVAX -0.13
- SPHR -0.26
- Stochastic Oscillator
- NVAX 1.62
- SPHR 50.56
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.